60 Degrees Pharmaceuticals Inc.
SXTP | NASDAQ
$1.07
+$0.06 (+5.94%)
Sep 22, 2026, 11:06 AM ET · Market open
Market Data
Market Cap $814.62K
Enterprise Value $-207.99K
Beta 2.54
Average Volume 91.78K
Shares Outstanding (Diluted) 2.65M
Shares Change YoY 620.72%
Institutional Ownership 11.26%
Exchange NASDAQ
ISIN US83006G5009
Price Performance
Price Change 1M -11.4%
Price Change 3M -39.9%
Price Change 6M -34.8%
Price Change YTD -51.0%
Price Change 1Y -81.7%
Price Change 3Y -99.4%
Price Change 5Y -99.9%
1M CAGR (ann.) -9.8%
1Y CAGR (ann.) -82.7%
5Y CAGR (ann.) N/A
All-Time CAGR -88.8%
Valuation
PE Ratio -0.17
Forward PE N/A
PEG Ratio -0.00
Forward PEG -0.01
PS Ratio 0.73
Forward PS 0.60
PB Ratio 0.32
P/FCF Ratio -0.21
P/Adj. FCF Ratio -0.20
P/OCF Ratio -0.31
EV/Sales -0.19
EV/EBIT 0.04
EV/EBITDA 0.03
EV/FCF 0.05
Earnings Yield -599.0%
FCF Yield -484.5%
Adj. FCF Yield -498.3%
Financial Health
Net Cash $1.02M
Total Debt $0
Cash & Short-Term Investments $1.02M
Total Assets $4.28M
Current Ratio 2.32
Quick Ratio 1.78
Debt / Equity Ratio 0.06
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt N/A
Interest Coverage -1,134.85
Altman Z-Score -17.45
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 19.4%
Operating Profit Margin -774.9%
EBITDA Margin -726.0%
Net Profit Margin -730.2%
FCF Margin -355.3%
Adj. FCF Margin -365.4%
SBC / Revenue 10.1%
SBC Impact (per share) -2.8%
Returns
Return on Assets -189.4%
Return on Equity -211.6%
Return on Invested Capital -321.2%
Return on Capital Employed -321.5%
Return on Tangible Assets -204.1%
Historical Growth (CAGR)
Revenue CAGR 3Y 87.2%
Revenue CAGR 5Y -14.3%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 5.0%
EPS CAGR 5Y -45.1%
EPS CAGR 10Y N/A
FCF CAGR 3Y 21.5%
FCF CAGR 5Y -45.4%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Hold
Analyst Count 2
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Nov 11, 2026
EPS Estimate (next Q) -$0.61
EPS Growth Est (next Q) -76.9%
Revenue Est (next Q) $270K
Revenue Growth Est (next Q) -46.0%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $13.85
Price Target Upside 1271.3%
Cash Flow
Operating Cash Flow $-3.8M
Free Cash Flow $-3.95M
Adj. Free Cash Flow $-4.06M
FCF Per Share -$3.37
OCF Per Share -$3.31
OCF/S Ratio -789.8%
Income Statement
Revenue $1.11M
Gross Profit $215.79K
Operating Income $-8.61M
EBITDA $-8.05M
Net Income $-8.11M
EPS (Diluted) -$6.05
Revenue / Employee $370.33K
Profit / Employee $-2.7M
Employees 3
Add to Watchlist
Select watchlists to add or remove SXTP